A carregar...
Drug safety and immunogenicity of tumour necrosis factor inhibitors: the story so far
TNF-α inhibitor (TNFi) therapies have transformed the treatment of several rheumatic musculoskeletal diseases. However, the majority of TNFi’s are immunogenic and consequent anti-drug antibodies formation can impact on both treatment efficacy and safety. Several controversies exist in the area of im...
Na minha lista:
| Publicado no: | Rheumatology (Oxford) |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6199532/ https://ncbi.nlm.nih.gov/pubmed/29325166 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kex434 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|